Table 2:
Parameter | T2 vs Matched Postpartum (n=5) | T3 vs Matched Postpartum (n=5) | |||||
---|---|---|---|---|---|---|---|
T2 | PP | P-Value | T3 | PP | P-Value | ||
Css (μM/g) | 0.33 [0.08–1.2] | 0.53 [0.11–1.3] | 0.4787 | 0.44 [0.19–1.2] | 0.41 [0.11–1.1] | 0.8056 | |
CLR (L/h) | 2.4 [0.77–6.4] | 1.1 [0.09–18.5] | 0.4548 | 1.8 [0.26–11.8] | 1.9 [0.26–18.5] | 0.97 | |
Css OH-BUP (μM/g) | 15.1 [10.6–18.7] | 16.3 [4.9–39.6] | 0.7839 | 16.5 [6.3–30.9] | 13.3 [4.9–39.6] | 0.6896 | |
CLR (L/h) | 0.20 [0.11–0.36] | 0.10 [0.02–0.54] | 0.2937 | 0.08 [0.04–0.12] | 0.10 [0.03–0.46] | 0.5539 | |
CLf (L/h) | 50.7 [9.9–400.9] | 13.4 [1.7–120.8] | 0.1619 | 24.9 [5.8–71.2] | 15.9 [3.1–120.8] | 0.228 | |
Css (μM/g) | 0.73 [0.20–1.4] | 0.78 [0.10–2.2] | 0.7772 | 0.83 [0.36–1.7] | 0.64 [0.10–2.2] | 0.4699 | |
CLR (L/h) | 0.93 [0.31–3.4] | 0.35 [0.09–3.5] | 0.1707 | 0.40 [0.24–0.72] | 0.47 [0.09–3.5] | 0.7751 | |
SS-OH-BUP/ BUP | 2.2 [1.0–6.0] | 1.5 [0.7–5.9] | 0.4729 | 1.9 [0.9–8.7] | 1.6 [0.8–5.9] | 0.4943 | |
Css (μM/g) | 15.8 [10.0–22.2] | 15.9 [5.5–35.7] | 0.9786 | 13.7 [5.9–21.2] | 14.0 [5.5–35.7] | 0.9647 | |
CLR (L/h) | 0.15 [0.07–0.32] | 0.08 [0.02–0.45] | 0.3564 | 0.07 [0.05–0.09] | 0.09 [0.03–0.35] | 0.6659 | |
RR-OH-BUP/ BUP | 43.8 [16.4–178.7] | 32.5 [15.8–77.2] | 0.5907 | 33.7 [13.5–99.1] | 35.6 [15.2–77.2] | 0.8544 | |
Css (μM/g) | 3.4 [1.8–6.7] | 4.1 [1.2–10.8] | 0.4896 | 4.9 [3.1–10.7] | 4.7 [1.2–10.8] | 0.8675 | |
CLR (L/h) | 3.9 [1.7–8.6] | 2.4 [0.55–17.6] | 0.381 | 2.0 [1.1–2.8] | 2.9 [0.59–17.6] | 0.5748 | |
CLf (L/h) | 89.4 [20.1–275.8] | 34.5 [2.9–166.4] | 0.2477 | 56.6 [17.0–208.0] | 68.5 [15.8–166.4] | 0.5949 | |
Threo/ BUP | 10.3 [4.8–23.1] | 7.8 [3.5–17.6] | 0.545 | 11.2 [5.6–16.6] | 11.5 [9.7–17.6] | 0.8878 | |
Css (μM/g) | 0.49 [0.33–0.78] | 0.67 [0.25–1.7] | 0.2739 | 0.63 [0.52–0.79] | 0.80 [0.25–1.7] | 0.4832 | |
CLR (L/h) | 2.1 [0.91–4.4] | 1.6 [0.36–9.7] | 0.5107 | 1.2 [0.74–1.7] | 1.9 [0.36–9.7] | 0.4811 | |
CLf (L/h) | 23.8 [3.9–105.8] | 10.6 [1.3–70.7] | 0.3067 | 17.9 [4.1–112.1] | 21.1 [4.9–70.7] | 0.5992 | |
Erythro/ BUP | 1.5 [0.4–4.2] | 1.3 [0.5–3.2] | 0.771 | 1.4 [0.6–2.7] | 1.9 [1.2–3.2] | 0.1358 | |
Threo-OH | CLf (L/h) | 2.4 [0.4–12.4] | 1.2 [0.4–4.9] | 0.0809 | 1.7 [0.2–8.9] | 1.7 [0.4–4.9] | 0.9983 |
Erythro-OH | CLf (L/h) | 10.8 [3.2–39.8] | 5.1 [1.7–20.8] | 0.025 | 9.4 [2.5–36.7] | 7.6 [2.6–20.8] | 0.556 |
4’OH-BUP | CLf (L/h) | 1.5 [0.1–28.2] | 0.7 [0.0–5.7] | 0.6186 | 0.8 [0.1–4.8] | 1.0 [0.3–5.7] | 0.3921 |
OH-BUP, hydroxybupropion; Threo, threohydrobupropion; Erythro, erythrohydrobupropion; 4’OH-BUP, 4’-hydroxy-bupropion; T2, second trimester; T3, third trimester; PP, postpartum (defined as 6–12 weeks after delivery)
Values shown above include the geometric mean and [range]. Data were log-transformed for analysis with paired t-test
Steady-state concentrations (Css) are presented as dose-normalized.